Although there has been great progress in treating human immunodeficiency virus 1 (HIV-1) infection1, preventing transmission has thus far proven an elusive goal. Indeed, recent trials of a candidate vaccine and microbicide have been disappointing, both for want of efficacy and concerns about increased rates of transmission2,3,4. Nonetheless, studies of vaginal transmission in the simian immunodeficiency virus (SIV)–rhesus macaque (Macacca mulatta) model point to opportunities at the earliest stages of infection in which a vaccine or microbicide might be protective, by limiting the expansion of infected founder populations at the portal of entry5,6. Here we show in this SIV–macaque model, that an outside-in endocervical mucosal signalling system, involving MIP-3α (also known as CCL20), plasmacytoid dendritic cells and CCR5+cell-attracting chemokines produced by these cells, in combination with the innate immune and inflammatory responses to infection in both cervix and vagina, recruits CD4+ T cells to fuel this obligate expansion. We then show that glycerol monolaurate—a widely used antimicrobial compound7 with inhibitory activity against the production of MIP-3α and other proinflammatory cytokines8—can inhibit mucosal signalling and the innate and inflammatory response to HIV-1 and SIV in vitro, and in vivo it can protect rhesus macaques from acute infection despite repeated intra-vaginal exposure to high doses of SIV. This new approach, plausibly linked to interfering with innate host responses that recruit the target cells necessary to establish systemic infection, opens a promising new avenue for the development of effective interventions to block HIV-1 mucosal transmission.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Fauci, A. S. 25 years of HIV. Nature 453, 289–290 (2008)
Ledford, H. HIV vaccine may raise risk. Nature 450, 325 (2007)
Check, E. Scientists rethink approach to HIV gels. Nature 446, 12 (2007)
Cohen, J. AIDS research. Microbicide fails to protect against HIV. Science 319, 1026–1027 (2008)
Haase, A. T. Perils at mucosal front lines for HIV and SIV and their hosts. Nature Rev. Immunol. 5, 783–792 (2005)
Miller, C. J. et al. Propagation and dissemination of infection after vaginal transmission of SIV. J. Virol. 79, 9217–9227 (2005)
Kabara, J. J. in Cosmetic and Drug Preservation (eds Kabara, J. J. et al.) 305–322 (Marcel Dekker, Inc, 1984)
Peterson, M. L. & Schlievert, P. M. Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. Biochemistry 45, 2387–2397 (2006)
Li, Q. et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434, 1148–1152 (2005)
Mattapallil, J. J. et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434, 1093–1097 (2005)
Colonna, M., Trinchieri, G. & Liu, Y. J. Plasmacytoid dendritic cells in immunity. Nature Immunol. 5, 1219–1226 (2004)
Estes, J. D. et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 193, 703–712 (2006)
Dieu-Nosjean, M. C., Vicari, A., Lebecque, S. & Caux, C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J. Leukoc. Biol. 66, 252–262 (1999)
Schlievert, P. M., Deringer, J. R., Kim, M. H., Projan, S. J. & Novick, R. P. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob. Agents Chemother. 36, 626–632 (1992)
Narimatsu, R., Wolday, D. & Patterson, B. K. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res. Hum. Retroviruses 21, 228–233 (2005)
Schlievert, P. M. et al. Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use. Antimicrob. Agents Chemother. 52, 4448–4454 (2008)
Crane-Godreau, M. A. & Wira, C. R. CCL20/macrophage inflammatory protein 3α and tumor necrosis factor α production by primary uterine epithelial cells in response to treatment with lipopolysaccharide or Pam3Cys. Infect. Immun. 73, 476–484 (2005)
Wira, C. R., Fahey, J. V., Sentman, C. L., Pioli, P. A. & Shen, L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 206, 306–335 (2005)
Wang, Y. et al. The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J. Virol. 79, 14355–14370 (2005)
Klasse, P. J., Shattock, R. J. & Moore, J. P. Which topical microbicides for blocking HIV-1 transmission will work in the real world? PLoS Med. 3, e351 (2006)
Ma, Z.-M., Abel, K., Rourke, T., Wang, Y. & Miller, C. J. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J. Virol. 78, 14048–14052 (2004)
Johnston, R. Microbicides 2002: an update. AIDS Patient Care STDS 16, 419–430 (2002)
Shattock, R. J. & Moore, J. P. Inhibiting sexual transmission of HIV-1 infection. Nature Rev. Microbiol. 1, 25–34 (2003)
Cline, A. N., Bess, J. W., Piatak, M. & Lifson, J. D. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34, 303–312 (2005)
Peterson, M. L. et al. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect. Immun. 73, 2164–2174 (2005)
Li, Q. et al. Functional genomic analysis of the response of HIV-1 infected lymphatic tissue to antiretroviral therapy. J. Infect. Dis. 189, 572–582 (2004)
We thank C. Miller and D. Lu at the California National Primate Research Center, for helpful discussion and virus stocks, J. Kemnitz at the Wisconsin National Primate Research Center, for discussion and administrative support, and C. O’Neill and T. Leonard for help with the manuscript and figures. This work was supported in part by National Institute of Health (NIH) grants R21 AI071976 and P01 AI066314 (A.T.H.), funds from the National Cancer Institute, NIH, under contracts N01-CO-12400 and HHSN266200400088C (J.D.L.), and grant number P51 RR000167 from the National Center for Research Resources, a component of the NIH, to the Wisconsin National Primate Research Center. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. This publication’s contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or NIH.
About this article
Cite this article
Li, Q., Estes, J., Schlievert, P. et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458, 1034–1038 (2009). https://doi.org/10.1038/nature07831
Scientific Reports (2021)
Evidence of a tolerogenic vaccine against AIDS in the Chinese macaque prefigures a potential human vaccine
Archives of Virology (2021)
Development of an in vitro macrophage screening system on the immunomodulating effects of feed components
Journal of Animal Science and Biotechnology (2020)
Inhibition of African swine fever virus in liquid and feed by medium-chain fatty acids and glycerol monolaurate
Journal of Animal Science and Biotechnology (2020)
Microbial function and genital inflammation in young South African women at high risk of HIV infection